アジア太平洋のELISA診断検査：2030年市場予測-地域別分析-導入、検査タイプ、用途、エンドユーザー別

アジア太平洋のELISA診断検査市場は、2022年に2億5,570万米ドルと評価され、2030年には5億308万米ドルに達すると予測され、2022～2030年のCAGRは8.8%で成長すると予測されます。

革新的製品の発売がアジア太平洋のELISA診断検査市場を強化

ELISA検査は、柔軟性、感度、使いやすさなど、さまざまな利点があるため、最も普及している免疫測定検査の1つです。また、ELISA検査キットの低価格と高性能検査に伴う多面的な適用性により、さまざまな研究やIVDの要件に理想的なソリューションとなっています。低コストの適用性により、検査キットの製品革新はヒトと動物研究の需要を高めています。また、メーカーは自社設備を備えたELISA検査キットの開発に注力しています。Innovative Research社は、凝固因子、生物種、抗体の同定に幅広い選択性を持つELISAキットを販売しています。「ヒト血液凝固第IX因子キット」もその一つです。ヒト凝固第IX因子抗原アッセイは、ヒト血漿中の全IX因子抗原の定量を目的としています。このキットは研究目的にのみ使用することが推奨され、試薬は最大96の臨床検査に利用することができます。さらに、COVID-19の大流行の中、各メーカーがELISA検査の革新的な製品を発売したことで、ヒトへのELISA検査の普及が加速しています。2022年12月、Pictor Limitedは「PictArray SARS-CoV-2抗体検査」の新製品発表を行った。この新製品はCOVID-19ウイルスに関連する感染を検出し、得られた臨床結果は患者や医師がSARS-CoV-2感染症の治療や管理を行う際に役立ちます。メーカーによる革新的なELISA検査キットの発売は、低コストで多面的な応用が可能で、さまざまな生物種に関連する多様な感染症の診断に効果的な臨床結果を提供することが期待されます。したがって、革新的な製品の発売は、長期的にはメーカーに有利な機会を提供すると考えられます。

アジア太平洋のELISA診断検査市場概要

中国は、感染症の脅威が流行する前に迅速に予防、検出、対応できる強力で弾力的な公衆衛生システムを有しています。中国の生態系は、14億人という膨大な人口と世界の家畜の50％を占めることから、中国とその他を脅かす可能性のある新興・再興・新型疾患のリスクをもたらしています。2023年9月にJournal of Global Health誌に掲載された論文では、中国南東部の江蘇省における届出可能な感染症の年間発生率と致死率に関する研究が行われました。この研究では、公衆衛生政策が、調査期間中の腸管、媒介、人獣共通感染症の発生率とそれに伴う致死率の減少に効果的であったが、梅毒やエイズを中心とする性感染症や血液媒介感染症の発生率は増加したと結論付けています。

さらに、世界各地に広がる航空路網の拡大により、COVID-19パンデミックのような、世界の貿易の中断、発病者の増加、死亡者の増加をもたらすパンデミックにつながる可能性のある感染症など、急速な感染拡大のリスクが劇的に高まっています。同国は、同国のELISA診断検査市場に関わる国内外の参入企業に有利な機会を提供すると期待されています。

アジア太平洋のELISA診断検査市場の収益と2030年までの予測（金額）

アジア太平洋のELISA診断検査市場のセグメンテーション

アジア太平洋のELISA診断検査市場は、導入、検査タイプ、用途、エンドユーザー、国に基づいてセグメント化されます。採用に基づいて、アジア太平洋のELISA診断検査市場はヒトと動物に二分されます。2022年の市場シェアはヒトが大きいです。

検査タイプ別では、アジア太平洋のELISA診断検査市場はサンドイッチELISA、間接ELISA、競合ELISA、マルチプル＆ポータブルELISAに区分されます。間接ELISAセグメントが2022年に最大の市場シェアを占めました。

用途別では、アジア太平洋のELISA診断検査市場は自己免疫疾患、感染症、がん診断、タンパク質定量、その他に区分されます。感染症セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋のELISA診断検査市場は、病院＆診断センター、製薬＆バイオテクノロジー企業、動物病院＆診断ラボ、その他に区分されます。病院＆診断センターセグメントが2022年に最大の市場シェアを占めました。

国別に見ると、アジア太平洋のELISA診断検査市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。2022年のアジア太平洋のELISA診断検査市場シェアは中国が独占しました。

Bio-Rad Laboratories Inc.、Idexx Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Pictor Ltd.、DiaSorin SpA、Elabscience Biotechnology Inc.、Bio-Techne Corp.は、アジア太平洋のELISA診断検査市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 アジア太平洋のELISA診断検査市場：主要産業力学

• 主要市場促進要因
  • 動物における感染症の増加
  • ヒトの感染症発生率の増加
• 主要市場抑制要因
  • 製品回収の発生
• 主要市場機会
  • 革新的な製品の上市
• 今後の動向
  • ELISAベースの手順の進歩

第5章 ELISA診断検査市場：アジア太平洋市場分析

• イントロダクション
• アジア太平洋のELISA診断検査市場売上高、2022～2030年

第6章 アジア太平洋のELISA診断検査市場：収益と2030年までの予測：導入別

• イントロダクション
• アジア太平洋のELISA診断検査市場：2022年・2030年導入別売上高シェア（%）
• ヒト
• 動物

第7章 アジア太平洋のELISA診断検査市場：収益と2030年までの予測：検査タイプ別

• イントロダクション
• アジア太平洋のELISA診断検査市場：2022年・2030年検査タイプ別売上高シェア（%）
• サンドイッチELISA
• 間接ELISA
• 競合ELISA
• マルチプル＆ポータブルELISA

第8章 アジア太平洋のELISA診断検査市場：用途別収益と2030年までの予測

• イントロダクション
• アジア太平洋のELISA診断検査市場：2022年・2030年用途別売上高シェア（%）
• 自己免疫疾患
• 感染症
• がん診断
• タンパク質定量
• その他

第9章 アジア太平洋のELISA診断検査市場：エンドユーザー別収益と2030年までの予測

• イントロダクション
• アジア太平洋のELISA診断検査市場：2022年・2030年エンドユーザー別売上高シェア（%）
• 病院・診断センター
• 製薬・バイオテクノロジー企業
• 動物病院・診断ラボ
• その他

第10章 アジア太平洋のELISA診断検査市場：2030年までの収益と予測：国別分析

• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋

第11章 ELISA診断検査市場-業界情勢

• イントロダクション
• ELISA診断検査市場の成長戦略
• 有機的成長戦略
• 無機的成長戦略

第12章 企業プロファイル

• Bio-Rad Laboratories Inc
• Idexx Laboratories Inc
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc
• Abbott Laboratories
• Danaher Corp
• Pictor Ltd
• DiaSorin SpA
• Elabscience Biotechnology Inc
• Bio-Techne Corp

第13章 付録

List Of Tables

• Table 1. ELISA Diagnostic Test Market Segmentation
• Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
• Table 3. China ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 4. China ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 5. China ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 6. China ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 7. Japan ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 8. Japan ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 9. Japan ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 10. Japan ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 11. India ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 12. India ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 13. India ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 14. India ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 15. Australia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 16. Australia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 17. Australia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 18. Australia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 19. South Korea ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 20. South Korea ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 21. South Korea ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 22. South Korea ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 23. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
• Table 24. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
• Table 25. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 26. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
• Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
• Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
• Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

• Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
• Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
• Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
• Figure 4. Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
• Figure 5. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
• Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
• Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
• Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
• Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 25. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
• Figure 26. China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 27. Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 28. India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 29. Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 30. South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 31. Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 32. Growth Strategies in ELISA diagnostics test Market

The Asia Pacific ELISA diagnostics tests market was valued at US$ 255.70 million in 2022 and is expected to reach US$ 503.08 million by 2030; it is estimated to grow at a CAGR of 8.8% from 2022 to 2030.

Innovative Product Launches Bolster Asia Pacific ELISA Diagnostics Tests Market

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities. Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests. Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans. In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Asia Pacific ELISA Diagnostics Tests Market Overview

China has a strong and resilient public health system that can rapidly prevent, detect, and respond to infectious disease threats before they become epidemics. China's ecology poses a risk for emerging, re-emerging, and novel diseases that could threaten China and the Rest of world owing to the vast population of ~ 1.4 billion and 50% of the world's livestock. In an article published by Journal of Global Health in September 2023, a study was carried out on annual incidence and fatality rates of notifiable infectious diseases in Jiangsu province of southeast China. The study concluded that public health policies have been effective in reducing the incidence of intestinal, vector-borne, and zoonotic diseases during the study period and the associated fatality, but that the incidence of sexually transmitted and blood-borne diseases, mainly syphilis and AIDS, has increased.

Additionally, growing network of air travel routes across the world dramatically increases the risk of rapid infection spread, including infections that may lead to pandemics, such as the COVID-19 pandemic, that result in disruption of global trade, rise in illness cases, or increase in deaths. The country is expected to provide lucrative opportunities to local and international players involved in ELISA diagnostics test market in the country.

Asia Pacific ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific ELISA Diagnostics Tests Market Segmentation

The Asia Pacific ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Asia Pacific ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Asia Pacific ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Asia Pacific ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Asia Pacific ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Asia Pacific ELISA diagnostics tests market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Asia Pacific ELISA diagnostics tests market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation
  • 1.2.1 Asia Pacific ELISA Diagnostic Tests Market - by Adoption
  • 1.2.2 Asia Pacific ELISA Diagnostic Tests Market - by Test Type
  • 1.2.3 Asia Pacific ELISA Diagnostic Tests Market - by Application
  • 1.2.4 Asia Pacific ELISA Diagnostic Tests Market - by End User
  • 1.2.5 Asia Pacific ELISA Diagnostic Tests Market - by Country

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific ELISA Diagnostic Test Market - Key Industry Dynamics

• 4.1 Key Market Drivers
  • 4.1.1 Rising Infectious Diseases Among Animals
  • 4.1.2 Increasing Incidence of Human Infections
• 4.2 Key Market Restraints
  • 4.2.1 Incidents of Product Recalls
• 4.3 Key Market Opportunities
  • 4.3.1 Innovative Product Launches
• 4.4 Future Trends
  • 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - Asia Pacific Market Analysis

• 5.1 Overview
• 5.2 Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

• 6.1 Overview
• 6.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
• 6.3 Human
  • 6.3.1 Overview
  • 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Veterinary
  • 6.4.1 Overview
  • 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

• 7.1 Overview
• 7.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
• 7.3 Sandwich ELISA
  • 7.3.1 Overview
  • 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Indirect ELISA
  • 7.4.1 Overview
  • 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Competitive ELISA
  • 7.5.1 Overview
  • 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Multiple & Portable ELISA
  • 7.6.1 Overview
  • 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

• 8.1 Overview
• 8.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Autoimmune Diseases
  • 8.3.1 Overview
  • 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Infectious Disease
  • 8.4.1 Overview
  • 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Cancer Diagnosis
  • 8.5.1 Overview
  • 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Protein Quantification
  • 8.6.1 Overview
  • 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 8.7 Others
  • 8.7.1 Overview
  • 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

• 9.1 Overview
• 9.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals & Diagnostic Centers
  • 9.3.1 Overview
  • 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Pharmaceutical & Biotechnology Companies
  • 9.4.1 Overview
  • 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Veterinary Hospitals & Diagnostic Laboratories
  • 9.5.1 Overview
  • 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

• 10.1 Asia Pacific: ELISA Diagnostic Tests Market
  • 10.1.1 Asia Pacific: ELISA Diagnostic Tests Market, by Country
    • 10.1.1.1 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.1 Overview
      • 10.1.1.1.2 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
      • 10.1.1.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 10.1.1.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.1 Overview
      • 10.1.1.2.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
      • 10.1.1.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 10.1.1.3 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.1 Overview
      • 10.1.1.3.2 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
      • 10.1.1.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 10.1.1.4 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.4.1 Overview
      • 10.1.1.4.2 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
      • 10.1.1.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 10.1.1.5 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.5.1 Overview
      • 10.1.1.5.2 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
      • 10.1.1.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 10.1.1.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.6.1 Overview
      • 10.1.1.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
      • 10.1.1.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
      • 10.1.1.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in ELISA diagnostics test Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Bio-Rad Laboratories Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Idexx Laboratories Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 F. Hoffmann-La Roche Ltd
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Thermo Fisher Scientific Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Abbott Laboratories
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Danaher Corp
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Pictor Ltd
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 DiaSorin SpA
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Elabscience Biotechnology Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Financial Overview
  • 12.9.4 SWOT Analysis
  • 12.9.5 Key Developments
• 12.10 Bio-Techne Corp
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms